Prosecution Insights
Last updated: October 04, 2026

Fuller Ip Law LLC

Technology area: Biotechnology & Pharmaceuticals

80 pending office actions • 51 clients • 77 examiners • 47 art units • 0 of 80 (0%) have an AI response strategy ready

Analysis

FULLER IP LAW LLC specializes in Biotechnology & Pharmaceuticals. The firm has handled 756 career applications and currently manages 63 pending office actions. This indicates a focused and active practice in the life sciences.

The firm reports a resolved allowance rate of 86.83 percent. It takes an average of 3.16 office actions to secure an allowance. These statistics demonstrate a high level of effectiveness for a boutique firm in the competitive biotech sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=756 apps, methodology: how we score firms)

86.8%
Allowance Rate
n=756
+0.67σ
Allowance Rate (norm)
n=756
3.2
OAs to Allowance
n=310
-0.32σ
OAs to Allow (norm)
n=310
1044 days
Time to Allowance
n=310
+11.4pp
Interview Lift
n=756
29.7%
RCE Rate
n=756
0.8%
Appeal Rate
n=756

Rejection Performance (% of received rejections ultimately overcome)

53.8%
§101 Overcome
n=65
51.4%
§102 Overcome
n=183
52.5%
§103 Overcome
n=303
59.6%
§112 Overcome
n=270

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
32%
Top-3 CPC Share
n=756
2
Practitioners
n=756
378.0
Apps / Practitioner
n=756

Portfolio Summary

80
Total Pending OAs
48
Non-Final OAs
30
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

13
Overdue
1
Due this week
5
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (13)Due ≤ 7 days (1)Due ≤ 30 days (5)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

51
Hard (64%)
23
Medium (29%)
6
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other7 (9%)
§103 only16 (20%)
§102 only2 (2%)
§112 only4 (5%)
Double-patenting only2 (2%)
Double-patenting + other5 (6%)
Multi-statute (no §101)44 (55%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

44
Life Sciences
55% of docket
1
Information Tech
1% of docket
2
Communications
2% of docket
3
Semiconductors
4% of docket
10
Mechanical / Eng
12% of docket
20
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

800 h
Manual time on pending OAs
160 h
Time saved (low, 20%)
280 h
Time saved (mid, 35%)
7.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAUER, NICOLA MARIA 2 58.3% +50.0%
CLAUDIO VAZQUEZ, ADRIANA PAOLA 2 — —
LEE, JAE W 2 65.8% +38.6%
WANG, MICHAEL H 1 52.1% +25.5%
FAN, WEIHUA 1 83.4% +12.6%
CORDOVA RODRIGUEZ, ULARISLAO 1 87.5% +14.3%
ZHENG, LI 1 83.6% +12.9%
RAHMAN, MASUDUR 1 72.7% +31.7%
AMARA, MOHAMED K 1 75.8% +29.8%
BLACK-CHILDRESS, RAJSHEED O 1 63.0% +23.8%

Hard Cases (51)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18111875 Methods of Profiling Mass Spectral Data Using Neural Networks PHAM, TUAN A 98d overdue
18291554 TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD PATEL, NIKETA I 38d overdue
18448685 ANTI-MICROBIAL ANTIBODY SIGNATURES OF INFLAMMATORY BOWEL DISEASE AND USES THEREOF GRASER, JENNIFER E 17d overdue
18701580 SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA AKAR, SERKAN 10d overdue
17045746 IMPROVED MANEUVERABILITY AERIAL VEHICLE AND A METHOD IMPLEMENTED FOR THIS PURPOSE GORDON, ANNA L 3d overdue
18570611 SUB-MICRON PARTICLE SHOMER, ISAAC 12d
18040810 CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING LEE, JAE W 15d
18656551 METHODS OF DETECTING SOMATIC AND GERMLINE VARIANTS IN IMPURE TUMORS ROSARIO, DENNIS 22d

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18040810 CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING LEE, JAE W 15d
19428474 TRACKABLE PET TOYS WANG, MICHAEL H —
19125664 EPISTATIC TOMATO QTLS FOR INCREASING YIELD FAN, WEIHUA —
19190542 POWER CONVERTER CORDOVA RODRIGUEZ, ULARISLAO —
19169933 GENE EXPRESSION ELEMENTS AND SYSTEMS AND USE THEREOF ZHENG, LI —
18900613 CULTURED MEAT COMPOSITIONS RAHMAN, MASUDUR —
18896776 TERRESTRIAL OBSERVING NETWORK FOR DIGITAL TWINS: REAL-TIME 3D MAPPING OF METRIC, SEMANTIC, TOPOLOGICAL, AND PHYSICOCHEMICAL PROPERTIES FOR OPTIMAL ENVIRONMENTAL MONITORING AMARA, MOHAMED K —
18886876 HIGH-ALTITUDE BALLOON PAYLOAD WITH ATTITUDE CONTROL AND PREDICTIVE SCHEDULING, FOR AEROBIOLOGICAL SAMPLING AND ENVIRONMENTAL MONITORING BLACK-CHILDRESS, RAJSHEED O —

Client Portfolio (51 clients)

Client (Assignee)Pending OAs
Columbia University 11
Arizona State University 8
Hansoh Pharmaceutical 4
TGen 3
ALEPH FARMS LTD. 2
Dyadic International (Usa), Inc. 2
Mayo Foundation for Medical Education & Research 2
Triple W 2
Ecoplanet Environmental LLC 2
Hebrew University of Jerusalem 2
SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. 2
Carken Co., LLC 1
Yissum Research Development Company Of The Hebrew University Of Jerusalem Lt 1
Higher Wire, Inc. 1
Geneneer Ltd. 1
Desert Botanical Gardens 1
Emmetrope Ophthalmics LLC 1
Haisco Pharmaceutical 1
University Of Nebraska-Lincoln 1
Nrgene Technologies Ltd. 1
Ambassador Asset Management Limited Partnership 1
Signet Therapeutics Inc. 1
Oryx Additive, Inc. 1
Smudge Pot Direct LLC 1
Weizmann Institute of Science 1
NEWSOUTH INNOVATIONS PTY LIMITED 1
Renergi Pty Ltd. 1
OCUSUN OPHTHALMIC PHARMACEUTICAL (GUANGZHOU) CO., LTD. 1
UNIVERSITEIT ANTWERPEN 1
Guangzhou National Laboratory 1
IMPERIAL COLLEGE INNOVATIONS LIMITED 1
LDC Business Consulting 1
Grande Delta Corporation 1
SUPERIOR DERMATOLOGY SOLUTIONS LLC 1
Wisconsin Alumni Research Foundation 1
Sam Rx, Pllc 1
Emmecell, Inc. 1
Cedars-Sinai 1
INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES 1
RIVULIS PLASTRO LTD. 1
DALHOUSIE UNIVERSITY 1
Arizona Foundation Solutions, LLC 1
INSERM 1
Neurodex, Inc. 1
Mojia Biotech 1
THE UNIVERSITY OF NOTTINGHAM 1
Technion 1
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE 1
WATERFORD INSTITUTE OF TECHNOLOGY 1
AEROTOR UNMANNED SYSTEMS LTD. 1
Emmetrope, Inc. 1

Top Art Units

Art UnitApps
16563
16783
36422
16622
16522
16212
16292
16242
16842
16372

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19428474 TRACKABLE PET TOYS Carken Co., LLC WANG, MICHAEL H 3642 §103 Non-Final OA — Pending Dec 22, 2025
19125664 EPISTATIC TOMATO QTLS FOR INCREASING YIELD Yissum Research Development Company Of The Hebrew University Of Jerusalem Lt FAN, WEIHUA 1663 §101§112 Non-Final OA — Pending Apr 29, 2025
19190542 POWER CONVERTER Higher Wire, Inc. CORDOVA RODRIGUEZ, ULARISLAO §102§103 Non-Final OA — Pending Apr 25, 2025
19169933 GENE EXPRESSION ELEMENTS AND SYSTEMS AND USE THEREOF Geneneer Ltd. ZHENG, LI 1662 §103§112Other Non-Final OA — Pending Apr 03, 2025
18900613 CULTURED MEAT COMPOSITIONS Aleph Farms Ltd. RAHMAN, MASUDUR 1633 §101§102§103§112 Non-Final OA — Pending Sep 27, 2024
18896776 TERRESTRIAL OBSERVING NETWORK FOR DIGITAL TWINS: REAL-TIME 3D MAPPING OF METRIC, SEMANTIC, TOPOLOGICAL, AND PHYSICOCHEMICAL PROPERTIES FOR OPTIMAL ENVIRONMENTAL MONITORING Desert Botanical Gardens AMARA, MOHAMED K 2877 §103 Final Rejection — Pending Sep 25, 2024
18886876 HIGH-ALTITUDE BALLOON PAYLOAD WITH ATTITUDE CONTROL AND PREDICTIVE SCHEDULING, FOR AEROBIOLOGICAL SAMPLING AND ENVIRONMENTAL MONITORING Arizona Board of Regents BLACK-CHILDRESS, RAJSHEED O 2685 §103 Final Rejection — Pending Sep 16, 2024
18819967 METHODS AND COMPOSITIONS TO REGULATE MAPT SPLICING FOR MODELING AND TREATMENT OF TAUOPATHIES The Trustees of Columbia University in the City of New York KIEFER, DALTON EDWARD §103§112 Non-Final OA — Pending Aug 29, 2024
18839412 OCULAR SURGICAL MAGNET APPARATUS Emmetrope Ophthalmics LLC ACKUN, JACOB K §102§103 Non-Final OA — Pending Aug 16, 2024
18836350 PREPARATION METHOD OF PYRIDAZINONE DERIVATIVE, AND INTERMEDIATE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. PECKHAM, RICHARD GRANT §103§112 Non-Final OA — Pending Aug 06, 2024
18833879 PROPYLENE KETONE-CONTAINING BIOINHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. WHITE, DAWANNA SHAR-DAY §102§103§112 Non-Final OA — Pending Jul 26, 2024
18778748 LOW-COST ROBOTIC SHAKE TABLE AND METHOD FOR OPERATING THE SAME University Of Nebraska-Lincoln SINHA, TARUN §102§103 Non-Final OA — Pending Jul 19, 2024
18730751 A TOMATO PLANT COMPRISING DOMINANT RESISTANCE GENES TO TOMATO BROWN RUGOSE FRUIT VIRUS Nrgene Technologies Ltd. BYRNES, DAVID R 1662 §101§112 Non-Final OA — Pending Jul 19, 2024
18762553 SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF Arizona Board of Regents KOMATSU, LI N 1658 §112 Final Rejection 23d overdue Pending Jul 02, 2024
18723812 TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. JACKSON, SHAWQUIA §102§112 Non-Final OA — Pending Jun 24, 2024
18744407 BATTERY-POWERED, TEMPERATURE-CONTROLLED DEVICES AND METHODS FOR TRANSPORT, STORAGE, AND EXPERIMENTATION IN MICRO-GRAVITY RESEARCH AND MANUFACTURING APPLICATIONS Ambassador Asset Management Limited Partnership BONZELL, PHILIP J §102§103 Non-Final OA — Pending Jun 14, 2024
18719257 PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF Signet Therapeutics Inc. REILLY, SOPHIA JANE §102§103§112 Non-Final OA — Pending Jun 12, 2024
18717414 ECO-FRIENDLY METHOD, APPARATUS, AND SYSTEM FOR PRECIPITATION AND COLLECTION OF DISSOLVED SUPPORT MATERIAL Oryx Additive, Inc. GURTOWSKI, RICHARD C §102§103 Non-Final OA — Pending Jun 06, 2024
18677650 SMUDGE POT Smudge Pot Direct LLC SAVANI, AVINASH A §102§103 Non-Final OA — Pending May 29, 2024
18709413 EXPRESSION OF MULTIPLE IMMUNE-ACTIVE MOLECULES IN GENETICALLY-MODIFIED FILAMENTOUS FUNGI Dyadic International (Usa), Inc. MOAZZAMI, NAGHMEH NINA 1652 §103§112 Non-Final OA — Pending May 10, 2024
18656551 METHODS OF DETECTING SOMATIC AND GERMLINE VARIANTS IN IMPURE TUMORS The Translational Genomics Research Institute ROSARIO, DENNIS 2676 §102§103 Final Rejection 22d Pending May 06, 2024
18701580 SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA Yeda Research And Development Co. Ltd. AKAR, SERKAN 3797 §102§103§112 Non-Final OA 10d overdue Pending Apr 15, 2024
18700664 COMPOSITE INK FORMULATIONS FOR ENDOSCOPIC IMAGING Mayo Foundation for Medical Education and Research DONOHUE, SEAN R §102§103§112 Non-Final OA — Pending Apr 11, 2024
18622705 MNO NANOMATERIAL BASED INHIBITORS OF INFLAMMATION AND CANCER METASTASIS Newsouth Innovations Pty Ltd SCHLIENTZ, NATHAN W 1616 §102§103§112 Non-Final OA — Pending Mar 29, 2024
18622162 METHOD FOR MODULATING UNPRODUCTIVE ALTERNATIVE SPLICING The Trustees of Columbia University in the City of New York HUDSON, AMY ROSE §102§103§112 Non-Final OA — Pending Mar 29, 2024
18696937 APPARATUS AND METHOD FOR THERMAL PROCESSING Renergi Pty Ltd. MALLON, BRETT PETERSON §102§103§112 Non-Final OA — Pending Mar 28, 2024
18692247 METHOD FOR FABRICATING LAYERED SORBENT FILMS USING ADHESIVE Arizona Board of Regents GHORISHI, SEYED BEHROOZ 1748 §103 Final Rejection 3d overdue Pending Mar 14, 2024
18685883 AROMATIC RING-CONTAINING BIOLOGICAL ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. BAUER, NICOLA MARIA 1621 §102§103 Non-Final OA — Pending Feb 22, 2024
18682111 APPLICATION OF STEROID COMPOUND IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING EYE FLOATERS Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. ARCORIA, PAUL JOSEPH 1621 §103 Final Rejection — Pending Feb 07, 2024
18293637 CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. REDWOOD, CHRISTOPHER EVAN 1629 §103 Non-Final OA — Pending Jan 30, 2024
18293759 PROCESS FOR PRODUCING RECYCLED LACTATE SALT Triplew Ltd. CUTLIFF, YATE KAI RENE §103 Non-Final OA — Pending Jan 30, 2024
18291554 TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD UNIVERSITEIT ANTWERPEN PATEL, NIKETA I 3792 §102§103§112 Non-Final OA 38d overdue Pending Jan 23, 2024
18291209 SAMPLE EXTRACTION DEVICE Guangzhou National Laboratory RAMIREZ, ALEX §102§103§112 Non-Final OA — Pending Jan 22, 2024
18415537 ANTIMICROBIAL SOLUTIONS AND USES THEREOF Ecoplanet Environmental LLC MORNHINWEG, JEFFREY P 1793 §102§103 Non-Final OA — Pending Jan 17, 2024
18570611 SUB-MICRON PARTICLE Imperial College Innovations Limited SHOMER, ISAAC 1612 §102§103 Final Rejection 12d Pending Dec 14, 2023
18537982 SELF WARMING MEDICAL PRODUCTS, GELS, AND FLUIDS Ldc Business Consulting LLC OUYANG, BO 3794 §102§103 Non-Final OA 33d Pending Dec 13, 2023
18568728 METHODS OF PROCESSING COLLAGEN FROM ANIMAL TISSUE Grande Delta Corporation JONES-FOSTER, ERICA NICOLE 1656 §102§103 Non-Final OA — Pending Dec 08, 2023
18525163 VIBRATING ANESTHESIA DEVICE Superior Dermatology Solutions LLC GRASMEDER, SARAH DYMPNA 3783 §103 Final Rejection — Pending Nov 30, 2023
18556737 ANALYSIS OF FRAGMENT ENDS IN DNA Wisconsin Alumni Research Foundation WOITACH, JOSEPH T §101§103 Non-Final OA — Pending Oct 23, 2023
18491581 RIGID ENDOTRACHEAL INTUBATION STYLET Sam Rx, Pllc DITMER, KATHRYN ELIZABETH 3785 §102§103 Non-Final OA — Pending Oct 20, 2023
18484359 METHODS OF INCREASING BIOMASS PRODUCTIVITY IN ALGAE CULTURES Arizona Board of Regents PAPCIAK, SHARON M 1657 §103Other Final Rejection 15d overdue Pending Oct 10, 2023
18554199 THERAPEUTIC MODALITIES FOR INHIBITING PANCREATIC BETA CELL IMPAIRMENT AND TREATING DIABETES Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. HABTE, KAHSAY 1624 §102 Final Rejection — Pending Oct 05, 2023
18480489 TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF Arizona Board of Regents NGUYEN, NAM P 1678 §112DP Final Rejection 43d overdue Pending Oct 03, 2023
18552892 ORGANIC COMPOUNDS, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS Shaanxi Lighte Optoelectronics Material Co., Ltd. CLAUDIO VAZQUEZ, ADRIANA PAOLA §103 Non-Final OA — Pending Sep 27, 2023
18551863 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS Shaanxi Lighte Optoelectronics Material Co., Ltd. CLAUDIO VAZQUEZ, ADRIANA PAOLA 2899 §103§112Other Non-Final OA — Pending Sep 21, 2023
18551356 METHODS AND COMPOUNDS FOR NEOANTIGEN VACCINES The Translational Genomics Research Institute JOHANSEN, PETER N. §102§103 Non-Final OA — Pending Sep 19, 2023
18464846 COMPOSITIONS AND METHODS OF USE OF SYNTHETIC PEPTIDES WITH MYCOBACTERIUM ABSCESSUS INHIBITORY ACTIVITY Arizona Board of Regents BUNKER, AMY M 1684 DP Final Rejection — Pending Sep 11, 2023
18448685 ANTI-MICROBIAL ANTIBODY SIGNATURES OF INFLAMMATORY BOWEL DISEASE AND USES THEREOF Mayo Foundation for Medical Education and Research GRASER, JENNIFER E 1645 §101§102§112 Final Rejection 17d overdue Pending Aug 11, 2023
18362678 IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECS) Emmecell, Inc. GABEL, GAILENE 1678 §102§112Other Non-Final OA — Pending Jul 31, 2023
18261475 CRYSTALLIZATION OF HIGH-PURITY MAGNESIUM L-LACTATE Triplew Ltd. KELLY-O'NEILL, YOLANDA LYNNETTE 1692 §103 Final Rejection 11d overdue Pending Jul 13, 2023
18350077 METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME Cedars-Sinai Medical Center BRETZ, COREY LANE 1635 §103§112DP Final Rejection 6d Pending Jul 11, 2023
18259538 HUMAN PAPILLOMAVIRUS TYPE 18 CHIMERIC PROTEIN AND USE THEREOF Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences BOESEN, AGNIESZKA 1672 §112 Non-Final OA — Pending Jun 27, 2023
18259049 BIODEGRADABLE IRRIGATION PIPE Rivulis Plastro Ltd. DANDRIDGE, CHRISTOPHER R. 3752 §102§103 Final Rejection — Pending Jun 22, 2023
18254153 IMPROVING COGNITIVE FUNCTION Dalhousie University MARLEN, TAMMIE K 3796 §102§103 Non-Final OA — Pending May 23, 2023
18316806 SYSTEM AND METHOD OF FOUNDATION REPAIR DIAGNOSTICS AND REMEDIATION DESIGN Arizona Foundation Solutions, LLC TRAN, SCOTT THANH BINH §101§103§112 Non-Final OA — Pending May 12, 2023
18251222 A MULTI-SCAFFOLD SYSTEM FOR LARGE SCALE CULTIVATION OF CELLS Aleph Farms Ltd. MCGUIRK, JOHN SCHUYLER 1798 §103 Final Rejection 12d Pending Apr 28, 2023
18249058 LIPOPEPTIDE FUSION INHIBITORS AS SARS-COV-2 ANTIVIRALS INSERM BEANE, RANDALL L 1654 §103 Final Rejection 103d overdue Pending Apr 13, 2023
18121759 USE OF ANTI-CRISPR AGENTS TO CONTROL EDITING IN HUMAN EMBRYOS The Trustees of Columbia University in the City of New York LIPPOLIS, ALEXANDRA ROSE 1637 §103§112 Final Rejection — Pending Mar 15, 2023
18245140 DIAGNOSTIC ASSAYS EMPLOYING NEURON-DERIVED EXOSOMES Neurodex, Inc. CHERNYSHEV, OLGA N 1675 §112 Non-Final OA — Pending Mar 13, 2023
18111875 Methods of Profiling Mass Spectral Data Using Neural Networks The Translational Genomics Research Institute PHAM, TUAN A 2163 §101§103Other Final Rejection 98d overdue Pending Feb 20, 2023
18041618 NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER The Trustees of Columbia University in the City of New York KAMM, JUDITH MARIE 1611 §102§103§112DPOther Final Rejection 110d overdue Pending Feb 14, 2023
18040810 CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. LEE, JAE W 1656 §102§103§112 Non-Final OA 15d Pending Feb 06, 2023
18004174 COMPOSITION AND METHOD FOR TREATING INFECTIONS Ecoplanet Environmental LLC NEAGU, IRINA 1629 §102§103§112DP Non-Final OA — Pending Jan 03, 2023
18063048 BINDING SITE IN TYPE 2 RYANODINE RECEPTOR The Trustees of Columbia University in the City of New York BAUER, NICOLA MARIA 1684 §103§112Other Non-Final OA — Pending Dec 07, 2022
18073181 METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA The Trustees of Columbia University in the City of New York HUTTER, GILLIAN A 1625 §102§103 Final Rejection — Pending Dec 01, 2022
17924927 MODIFIED FILAMENTOUS FUNGI FOR PRODUCTION OF EXOGENOUS PROTEINS Dyadic International (Usa), Inc. LEITH, NANCY J 1636 §103§112 Non-Final OA — Pending Nov 11, 2022
18050423 BINDING SITE IN TYPE 1 RYANODINE RECEPTOR The Trustees of Columbia University in the City of New York HIBBERT, CATHERINE S 2878 §103§112 Non-Final OA — Pending Oct 27, 2022
17911409 BIO-BASED NYLON PRECURSORS HAVING REDUCED ORGANIC AND INORGANIC IMPURITIES Mojia Biotech Ltd. RAMIREZ, DELIA M 1652 §103§112 Final Rejection — Pending Sep 13, 2022
17905583 IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING The Trustees of Columbia University in the City of New York LEE, JAE W 1656 §102 Final Rejection — Pending Sep 02, 2022
17848308 SYSTEMS FOR CATALYTICALLY REMOVING PER- AND POLYFLUOROALKYL SUBSTANCES FROM A FLUID AND RELATED METHODS Arizona Board of Regents NORRIS, CLAIRE A 1779 §103§112Other Non-Final OA — Pending Jun 23, 2022
17776990 CORNEAL TISSUE The University of Nottingham BLANCO, JAVIER G 3774 §102§103§112 Non-Final OA — Pending May 13, 2022
17717697 GENE EDITING TO CORRECT ANEUPLOIDIES AND FRAME SHIFT MUTATIONS The Trustees of Columbia University in the City of New York ALLEN, SARAH ELIZABETH 1637 §103§112 Final Rejection — Pending Apr 11, 2022
17640327 COMBINATION ANTIVIRAL THERAPY FOR MEASLES Cornell University PARKIN, JEFFREY S 1671 §103§112 Non-Final OA — Pending Mar 03, 2022
17580219 INCREASING GENOME STABILITY AND REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS The Trustees of Columbia University in the City of New York GRABER, JAMES J 1631 §103 Final Rejection — Pending Jan 20, 2022
17618869 TARGETS AND METHODS OF DIAGNOSING, MONITORING AND TREATING FRONTOTEMPORAL DEMENTIA Arizona Board of Regents IVICH, FERNANDO NMN 1678 §112 Final Rejection 22d Pending Dec 13, 2021
17610863 SYSTEMS AND METHODS FOR PHENOTYPING Technion Research And Development Foundation Limited CLOW, LORI A 1687 §103 Final Rejection 131d overdue Pending Nov 12, 2021
17494218 PROPHYLACTIC EFFICACY OF SEROTONIN 4 RECEPTOR AGONISTS AGAINST STRESS Institut National de la Santé et de la Recherche Médicale BRAUN, MADELINE E 1624 §103 Non-Final OA — Pending Oct 05, 2021
17290857 ARTIFICIAL TEARS Waterford Institute Of Technology RICCI, CRAIG D 1611 DP Final Rejection — Pending May 03, 2021
17045746 IMPROVED MANEUVERABILITY AERIAL VEHICLE AND A METHOD IMPLEMENTED FOR THIS PURPOSE Aerotor Unmanned Systems Ltd. GORDON, ANNA L 3642 §103§112 Final Rejection 3d overdue Pending Oct 06, 2020
16561449 MAGNETIC CELLS FOR LOCALIZING DELIVERY AND TISSUE REPAIR Emmetrope, Inc. NOBLE, MARCIA STEPHENS 1632 §112DP Non-Final OA — Pending Sep 05, 2019

Managing Fuller Ip Law LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month